Taiwan · Delayed Price · Currency is TWD Ttbio Statistics
Total Valuation
Ttbio has a market cap or net worth of TWD 901.88 million. The enterprise value is 879.14 million.
| Market Cap | 901.88M |
| Enterprise Value | 879.14M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Ttbio has 24.05 million shares outstanding. The number of shares has increased by 24.71% in one year.
| Current Share Class | 30.05M |
| Shares Outstanding | 24.05M |
| Shares Change (YoY) | +24.71% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 2.81% |
| Owned by Institutions (%) | 1.26% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.03 |
| EV / EBITDA | 79.94 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.11 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 19.75 |
| Debt / FCF | -2.46 |
| Interest Coverage | -4.61 |
Financial Efficiency
Return on equity (ROE) is -4.53% and return on invested capital (ROIC) is -4.68%.
| Return on Equity (ROE) | -4.53% |
| Return on Assets (ROA) | -2.15% |
| Return on Invested Capital (ROIC) | -4.68% |
| Return on Capital Employed (ROCE) | -4.98% |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | 3.14M |
| Profits Per Employee | -106,362 |
| Employee Count | 138 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, Ttbio has paid 514,000 in taxes.
| Income Tax | 514,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.42% in the last 52 weeks. The beta is 0.58, so Ttbio's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -20.42% |
| 50-Day Moving Average | 40.79 |
| 200-Day Moving Average | 31.19 |
| Relative Strength Index (RSI) | 46.66 |
| Average Volume (20 Days) | 141,708 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ttbio had revenue of TWD 433.42 million and -14.68 million in losses. Loss per share was -0.49.
| Revenue | 433.42M |
| Gross Profit | 72.98M |
| Operating Income | -23.01M |
| Pretax Income | -14.16M |
| Net Income | -14.68M |
| EBITDA | 3.25M |
| EBIT | -23.01M |
| Loss Per Share | -0.49 |
Balance Sheet
The company has 86.62 million in cash and 217.20 million in debt, with a net cash position of -130.58 million or -5.43 per share.
| Cash & Cash Equivalents | 86.62M |
| Total Debt | 217.20M |
| Net Cash | -130.58M |
| Net Cash Per Share | -5.43 |
| Equity (Book Value) | 361.30M |
| Book Value Per Share | 12.02 |
| Working Capital | 260.58M |
Cash Flow
In the last 12 months, operating cash flow was -76.02 million and capital expenditures -12.27 million, giving a free cash flow of -88.29 million.
| Operating Cash Flow | -76.02M |
| Capital Expenditures | -12.27M |
| Depreciation & Amortization | 26.26M |
| Net Borrowing | -21.44M |
| Free Cash Flow | -88.29M |
| FCF Per Share | -3.67 |
Margins
Gross margin is 16.84%, with operating and profit margins of -5.31% and -3.39%.
| Gross Margin | 16.84% |
| Operating Margin | -5.31% |
| Pretax Margin | -3.27% |
| Profit Margin | -3.39% |
| EBITDA Margin | 0.75% |
| EBIT Margin | -5.31% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | -33.31% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.71% |
| Shareholder Yield | -24.19% |
| Earnings Yield | -1.63% |
| FCF Yield | -9.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ttbio has an Altman Z-Score of 2.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.59 |
| Piotroski F-Score | 2 |